Transforming growth factor-β receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways

被引:162
作者
Pannu, Jaspreet
Nakerakanti, Sashidhar
Smith, Edwin
ten Dijke, Peter
Trojanowska, Maria
机构
[1] Med Univ S Carolina, Div Rheumatol & Immunol, Charleston, SC 29425 USA
[2] Leiden Univ, Med Ctr, NL-2300 RC Leiden, Netherlands
关键词
D O I
10.1074/jbc.M611742200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transforming growth factor (TGF)- beta/Smad3 signaling pathway is considered a central mediator of pathological organ fibrosis; however, contribution of Smad2/3-independent TGF-beta signaling has not been fully explored. The present study utilized previously a described model of scleroderma (SSc) fibrosis based on forced expression of the TGF-beta RI ( ALK5) ( Pannu, J., Gardner, H., Shearstone, J. R., Smith, E., and Trojanowska, M. ( 2006) Arthritis Rheum. 54, 3011 - 3021). This study was aimed at determining the molecular mechanisms underlying the profibrotic program in this model. We demonstrate that the TGF-beta RI-dependent up-regulation of collagen and CCN2 ( CTGF) does not involve Smad2/3 activation but is mediated by ALK1/Smad1 and ERK1/2 pathways. The following findings support this conclusion: (i) Smad2 and - 3 were not phosphorylated in response to TGF-beta RI, ( ii) a TGF- beta RI mutant defective in Smad2/3 activation, ALK5( 3A), potently stimulated collagen production, (iii) elevation of TGF-beta RI triggered sustained association of ALK5 with ALK1 and high levels of Smad1 phosphorylation, (iv) blockade of Smad1 via small interfering RNA abrogated collagen and CCN2 up-regulation in this model, ( v) elevated TGF-beta RI led to a prolonged activation of ERK1/2, ( vi) the pharmacologic inhibitor of ERK1/2 inhibited Smad1 phosphorylation and abrogated profibrotic effects of elevated TGF beta-RI. Additional experiments demonstrated that a GC- rich response element located -6 to -16 ( upstream of the transcription start site) in the CCN2 promoter mediated Smad1- dependent increased promoter activity in this model. This element was shown previously to mediate up- regulation of the CCN2 promoter in SSc fibroblasts. In conclusion, this study defines a novel ALK1/Smad1- and ERK1/2-dependent, Smad3-independent mode of TGF-beta signaling that may operate during chronic stages of fibrosis in SSc.
引用
收藏
页码:10405 / 10413
页数:9
相关论文
共 46 条
[21]   Targeted disruption of TGF-β/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma [J].
Lakos, G ;
Takagawa, S ;
Chen, SJ ;
Ferreira, AM ;
Han, GW ;
Masuda, K ;
Wang, XJ ;
DiPietro, LA ;
Varga, J .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (01) :203-217
[22]   Connective tissue growth factor gene regulation -: Requirements for its induction by transforming growth factor-β2 in fibroblasts [J].
Leask, A ;
Holmes, A ;
Black, CM ;
Abraham, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (15) :13008-13015
[23]   TGF-β receptor function in the endothelium [J].
Lebrin, F ;
Deckers, M ;
Bertolino, P ;
ten Dijke, P .
CARDIOVASCULAR RESEARCH, 2005, 65 (03) :599-608
[24]   Smads 2 and 3 are differentially activated by transforming growth factor-β (TGF-β) in quiescent and activated hepatic stellate cells -: Constitutive nuclear localization of Smads in activated cells is TGF-β-independent [J].
Liu, CH ;
Gaça, MDA ;
Swenson, ES ;
Vellucci, VF ;
Reiss, M ;
Wells, RG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (13) :11721-11728
[25]   Smad transcription factors [J].
Massagué, J ;
Seoane, J ;
Wotton, D .
GENES & DEVELOPMENT, 2005, 19 (23) :2783-2810
[26]   TGF-β signal transduction [J].
Massagué, J .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :753-791
[27]   Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy [J].
Matsubara, T ;
Abe, H ;
Arai, H ;
Nagai, K ;
Mima, A ;
Kanamori, H ;
Sumi, E ;
Takahashi, T ;
Matsuura, M ;
Iehara, N ;
Fukatsu, A ;
Kita, T ;
Doi, T .
LABORATORY INVESTIGATION, 2006, 86 (04) :357-368
[28]   Decreased type II type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions - Conversion from an antiproliferative to profibrotic response to TGF-beta 1 [J].
McCaffrey, TA ;
Consigli, S ;
Du, BH ;
Falcone, DJ ;
Sanborn, TA ;
Spokojny, AM ;
Bush, HL .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (06) :2667-2675
[29]   TGF-β signaling by Smad proteins [J].
Miyazono, K ;
Ten Dijke, P ;
Heldin, CH .
ADVANCES IN IMMUNOLOGY, VOL 75, 2000, 75 :115-157
[30]   Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts [J].
Mori, Y ;
Chen, SJ ;
Varga, J .
ARTHRITIS AND RHEUMATISM, 2003, 48 (07) :1964-1978